{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-22-000948","form_type":"8-K","ticker":"UTMD","cik":"0000706698","company_name":"UTAH MEDICAL PRODUCTS INC","filed_at":"2022-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.418099+00:00","generated_at":"2026-06-26T04:17:27.537131+00:00","sec_items":["2.02","9.01","99.1"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"UTMD Q1 2022 revenue +12.4%, EPS +16.6%; operating margin expands to 36.7%","bullets":["Revenue $12.3M, up 12.4% YoY; domestic sales +18%, OUS +4% (constant currency +7%).","Net income $3.53M (+16.9%); diluted EPS $0.96 vs $0.82 in Q1 2021.","Gross margin contracted to 61.1% from 63.4% on higher raw material and freight costs.","Cash and investments $65.9M at Mar 31, 2022, up from $61.0M at Dec 31, 2021.","No regular dividend paid in Q1 2022; special $2.00/share dividend was paid in Dec 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-22-000948","json":"https://secwatch.observer/filing/0001096906-22-000948.json","markdown":"https://secwatch.observer/filing/0001096906-22-000948.md","text":"https://secwatch.observer/filing/0001096906-22-000948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/0001096906-22-000948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/706698/000109690622000948/utmd-20220426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:17:27.537131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}